BMP |
protein |
upregulated |
treatment |
therapeutic target |
N/A |
34360647 |
MMR protein |
protein |
methylation status |
treatment |
response to adjuvant therapy |
tissue |
33449452 |
HAI-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
20715109 |
HAI-2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
20715109 |
claudins |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
19795358 |
EphA2 |
protein |
upregulated |
treatment |
therapeutic targe in hormone receptor-negative EEC |
tissue |
19396818 |
superoxide dismutase(SOD) |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
18797802 |
superoxide dismutase(SOD) |
protein |
upregulated |
treatment |
therapeutic target |
serum |
18797802 |
aquaporin-1 (AQP1) |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
18313673 |
RCAS1 |
protein |
upregulated |
treatment |
predict treatment response |
serum |
16842844 |
CRBP-1 |
protein |
downgulated |
treatment |
therapeutic target |
tissue |
16575402 |
Twist |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
16564917 |
folate receptor alpha |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
33323854 |
p27 |
protein |
upregulated |
treatment |
predicting medroxyprogesterone acetate therapy |
tissue |
16515645 |
Human kallikrein 6 (hK6) |
DNA |
upregulated |
treatment |
response to therapy |
plasma |
15867230 |
Human kallikrein 6 (hK6) |
DNA |
upregulated |
treatment |
response to therapy |
serum |
15867230 |
Smad7 |
DNA |
upregulated |
treatment |
potential target to restore TGF-beta responsiveness |
tissue |
15661223 |
17beta-HSD type 2 |
protein |
in situ abundance |
treatment |
progestogen treatment |
tissue |
12780745 |
PRB |
protein |
in situ abundance |
treatment |
progestogen treatment |
tissue |
12780745 |
beta-catenin |
protein |
upregulated |
treatment |
progestogen treatment |
tissue |
12708483 |
AgNORs |
protein |
upregulated |
treatment |
predict sensitivity to radiotherapy |
tissue |
11917578 |
endostatin |
protein |
upregulated |
treatment |
predict treatment response |
serum |
11504312 |
VEGF |
protein |
upregulated |
treatment |
predict treatment response |
serum |
11504312 |
FTO |
DNA |
upregulated |
treatment |
therapeutic target |
tissue |
33103587 |
AL161431.1 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
32196580 |
BANCR |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
27898420 |
CCAT1 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
32173521 |
CDKN2A |
DNA |
hypermethylation |
treatment |
therapeutic targe |
N/A |
26283007 |
VEGFR2 |
protein |
upregulated |
treatment |
N/A |
tissue |
35241527 |
Musashi-1 |
protein |
upregulated |
treatment |
therapeutic target |
N/A |
35619161 |
SLERT |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
36721236 |
SLERT |
RNA |
upregulated |
treatment |
therapeutic target |
plasma |
36721236 |
HE4 |
protein |
upregulated |
treatment |
progestin treatment response |
plasma |
36715558 |
PDL-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35220229 |
FTO |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
33103587 |
PD-L1 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
TIM-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
B7-H3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35804040 |
lymphocyte activation gene-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissues |
35749914 |
L1CAM |
protein |
upregulated |
treatment |
platinum response |
tissue |
35429348 |
L1CAM |
DNA |
upregulated |
treatment |
platinum response |
tissue |
35429348 |
MMRd/MSI-H |
protein |
upregulated |
treatment |
response to immune checkpoint |
tissue |
34902958 |
apparent diffusion coefficient (ADC) |
Image |
DNA |
treatment |
fertility-sparing treatment |
Image |
35469683 |
HER2 |
protein |
upregulated |
treatment |
targeted therapy |
tissue |
36516643 |
HER2 |
protein |
upregulated |
treatment |
targeted therapy |
tissue |
36939053 |
mismatch repair status |
DNA |
mismatch repair deficiency |
treatment |
predict hormone therapy response |
tissue |
33039397 |
Lymphocyte activation gene (LAG)-3 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
36509464 |
MHC class I status |
protein |
downgulated |
treatment |
resistance mechanism to immune checkpoint inhibition |
tissue |
33011747 |
MHC class I status |
protein |
downgulated |
treatment |
selecting endometrial cancer patients for checkpoint inhibition |
tissue |
33011747 |
CDK9 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
32901849 |
hsa_circ_0002577 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
32847606 |
ARID1A |
protein |
downgulated |
treatment |
immune checkpoint inhibitor response |
tissue |
32594230 |
GABPA |
protein |
downgulated |
treatment |
therapeutic target |
tissue |
34306255 |
RRBP1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
30684972 |
SNF5 |
protein |
upregulated |
treatment |
therapies target/Knockdown of SNF5 inhibits the expression of p21 |
tissue |
30683081 |
endothelial (CD144+) |
protein |
upregulated |
treatment |
|
plasma |
30618036 |
monocytic (CD14+) |
protein |
upregulated |
treatment |
|
plasma |
30618036 |
the total amount of microparticles |
protein |
upregulated |
treatment |
|
plasma |
30618036 |
SMOC-2 |
protein |
upregulated |
treatment |
therapeutic target, enhanced resistance toward chemotherapy |
tissue |
30594556 |
Autotaxin |
DNA |
upregulated |
treatment |
therapeutic target |
tissue |
30374843 |
ALDH1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
30372483 |
CD44 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
30372483 |
ZIC2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
34278490 |
plasma amino acid profile-based index |
protein |
upregulated |
treatment |
predict treatment response and remission |
plasma |
30314462 |
PD-1 |
protein |
upregulated |
treatment |
potential target for immunotherapy |
tissue |
30134343 |
PD-L1 |
protein |
upregulated |
treatment |
potential target for immunotherapy |
tissue |
30134343 |
PD-L2 |
protein |
upregulated |
treatment |
potential target for immunotherapy |
tissue |
30134343 |
PR |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
AR |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
ER-alpha |
protein |
upregulated |
treatment |
therapeutic target and predictor of treatment response |
tissue |
29869299 |
ABHD11-AS1 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
29799152 |
PIR2 |
protein |
upregulated |
treatment |
targeted therapy |
tissue |
29724995 |
HOMA-IR |
OTHERS |
upregulated |
treatment |
predicted poor response to progestin |
serum |
34162378 |
RNF144B |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
29724995 |
CIP2A |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
29274810 |
HER2 |
protein |
upregulated |
treatment |
benefit of anti-HER2 treatments |
tissue |
29169184 |
IRAK1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
28980703 |
IRAK1 |
DNA |
upregulated |
treatment |
therapeutic target |
tissue |
28980703 |
SUSD2 |
protein |
downgulated |
treatment |
chemotherapeutic target |
N/A |
28841682 |
EMP2 |
protein |
upregulated |
treatment |
reducing endometrial cancer stem cells |
tissue |
28604744 |
EZH2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
28418882 |
miR-944 |
RNA |
upregulated |
treatment |
therapeutic targe |
tissue |
28178620 |
S100P |
protein |
upregulated |
treatment |
drug target,quamous cell and adenosquamous carcinoma subtypes of endometrial cancer |
tissue |
27918216 |
lncRNA NEAT1 |
RNA |
upregulated |
treatment |
therapeutic target |
tissue |
34153644 |
Fzd2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27373314 |
ERRα |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27153547 |
HDACs 1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 4 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 6 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 7 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
HDACs 8 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27127168 |
survivin |
protein |
upregulated |
treatment |
therapeutic target |
N/A |
27079211 |
SLUG |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
27003026 |
CD169 |
protein |
upregulated |
treatment |
monitoring anti-tumor immunity |
tissue |
26991548 |
glycine |
metabolite |
|
treatment |
novel target |
serum |
34099314 |
CXCR4 |
DNA |
upregulated |
treatment |
therapeutic targe |
N/A |
26678890 |
CXCR4 |
protein |
upregulated |
treatment |
therapeutic targe |
N/A |
26678890 |
CXCR7 |
DNA |
upregulated |
treatment |
therapeutic targe |
N/A |
26678890 |
CXCR7 |
protein |
upregulated |
treatment |
therapeutic targe |
N/A |
26678890 |
CCNE1 |
DNA |
upregulated |
treatment |
targeted therapy |
tissue |
26647729 |
TOP2A |
protein |
upregulated |
treatment |
receiving adjuvant taxane-platinum regimens |
tissue |
26588239 |
CDK6 |
protein |
upregulated |
treatment |
chemosensitive |
tissue |
26554657 |
CDK6 |
protein |
upregulated |
treatment |
chemosensitchenm ive |
tissue |
26554657 |
Sperm-associated antigen 9 (SPAG9) |
protein |
upregulated |
treatment |
progestin treatment |
tissue |
26334303 |
Sperm-associated antigen 9 (SPAG9) |
protein |
upregulated |
treatment |
progestin treatment |
tissue |
26334303 |
serine |
metabolite |
upregulated |
treatment |
novel target |
serum |
34099314 |
phosphoglucose isomerase (PGI) |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26308071 |
phosphoglucose isomerase (PGI) |
protein |
upregulated |
treatment |
therapeutic target |
serum |
26308071 |
CDC20 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26245990 |
Autocrine motility factor |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
26201353 |
Enolase-1 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
25951350 |
G9a |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
25613390 |
Yes-associated protein (YAP) |
protein |
upregulated |
treatment |
therapeutic target/predict radiation sensitivity |
tissue |
24972085 |
CYP1A1 |
protein |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
CYP1A1 |
DNA |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
CYP1B1 |
protein |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
SM C18:0 |
metabolite |
upregulated |
treatment |
novel target |
serum |
34099314 |
CYP1B1 |
DNA |
upregulated |
treatment |
chemotherapeutic targets |
tissue |
24957043 |
MRE11 |
protein |
downgulated |
treatment |
sensitivity to PARP-inhibitor |
tissue |
24927325 |
CGRRF1 |
DNA |
downgulated |
treatment |
metformin response |
tissue |
24680596 |
stathmin |
protein |
upregulated |
treatment |
paclitaxel treatment |
tissue |
24587245 |
CD117 |
protein |
upregulated |
treatment |
therapeutic targe(targeting of the SCF/CD117 axis) |
tissue |
24333732 |
hPEBP4 |
protein |
upregulated |
treatment |
potential target |
tissue |
23818363 |
ER-α36 |
protein |
upregulated |
treatment |
|
tissue |
23257935 |
ERRγ |
protein |
ERRγ-positive/ERα-negative status |
treatment |
predictive marker for the treatment |
tissue |
23051957 |
ERα |
protein |
ERRγ-positive/ERα-negative status |
treatment |
predictive marker for the treatment |
tissue |
23051957 |
BST2 |
protein |
upregulated |
treatment |
therapeutic target |
tissue |
22729361 |
free carnitine |
metabolite |
|
treatment |
novel target |
serum |
34099314 |
emmprin |
protein |
downgulated |
treatment |
theranostic target |
tissue |
22640183 |
miR-125b |
RNA |
aberrantly expressed |
treatment |
targeting ERBB2 |
tissue |
22460089 |
survivin |
DNA |
allele C |
treatment |
therapeutic implications |
tissue |
21897272 |
Ras-PI3K/mTOR pathway |
protein |
downgulated |
treatment |
predicting sensitivities to such agents |
N/A |
21772091 |
GDF-15 |
protein |
upregulated |
treatment |
monitoring treatment |
plasma |
21616994 |
epithelial cell size ratio |
Image |
higher epithelial cell size ratio after 4 weeks + lower Ki-67 nuclear antigen labeling |
treatment |
progestin therapy |
tissue |
21551965 |
Ki-67 nuclear antigen labeling |
protein |
higher epithelial cell size ratio after 4 weeks + lower Ki-67 nuclear antigen labeling |
treatment |
progestin therapy |
tissue |
21551965 |
Stathmin |
protein |
upregulated |
treatment |
redictive marker for response to PI3Kinase inhibition |
tissue |
21242118 |
E-cadherin |
protein |
upregulated |
treatment |
theranostic target |
tissue |
20874004 |
CDH1 |
DNA |
hypermethylation |
treatment |
therapeutic targe |
tissue |
20874004 |